- Home
- / Senti Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Senti Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.2
2024-10-29
Market Capitalization
$10.2 M
2024-10-29
Revenue
$22 K
FY, 2025
CreditSafe Score
?
Score changed on Jul 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 4.3M | 2.6M | 22.0K | ||
| General and administrative expense | 40.8M | 37.2M | 26.4M | 26.2M | |
| Operating expense total | 74.9M | 60.7M | 63.7M | ||
| EBIT | (3.9M) | (70.6M) | (92.7M) | (61.0M) | (68.8M) |
| EBIT margin, % | -1647.9% | -312631.8% | |||
| Investment income | 8.8K | ||||
| Interest expense | 1.7M | 2.9M | 948.0K | 927.0K | |
| Net Income | (3.9M) | (58.2M) | (71.1M) | (52.8M) | (61.4M) |
| EPS | (2.2) | (1.0) | (12.0) | (2.7) |